Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Assets: 2022-2024

Historic Return on Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to -0.08%.

  • Kiniksa Pharmaceuticals International's Return on Assets rose 20.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.08% for FY2024, which is 4.00% up from last year.
  • As of FY2024, Kiniksa Pharmaceuticals International's Return on Assets stood at -0.08%, which was up 36.29% from -0.12% recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Return on Assets ranged from a high of 0.77% in FY2022 and a low of -0.12% during FY2023.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Return on Assets averaged around 0.19%, with its median value being -0.08% (2024).
  • In the last 5 years, Kiniksa Pharmaceuticals International's Return on Assets plummeted by 89bps in 2023 and then climbed by 4bps in 2024.
  • Kiniksa Pharmaceuticals International's Return on Assets (Yearly) stood at 0.77% in 2022, then tumbled by 89bps to -0.12% in 2023, then rose by 4bps to -0.08% in 2024.